Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway.
作者:
主题词
AMP活化蛋白激酶类(AMP-Activated Protein Kinases);动物(Animals);纤维化(Fibrosis);血红素加氧酶-1(Heme Oxygenase-1);脂类代谢(Lipid Metabolism);肝(Liver);肝功能试验(Liver Function Tests);男(雄)性(Male);膜蛋白质类(Membrane Proteins);小鼠, 近交C57BL(Mice, Inbred C57BL);NF-E2相关因子2(NF-E2-Related Factor 2);肥胖症(Obesity);过氧化物酶类(Peroxidases)
DOI
10.1016/j.bbrc.2020.03.032
PMID
32171530
发布时间
2022-06-24
- 浏览19
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文